期刊文献+

血浆全段甲状旁腺激素测定在肾脏疾病中的临床应用 被引量:8

Clinical Application of Determination of Plasma Intact Parathyroid Hormone Content in Kidney Disease
下载PDF
导出
摘要 目的:探讨全段甲状旁腺激素(i-PTH)在肾脏疾病中的临床应用价值。方法:检测和分析了46例肾功能不全失代偿期组、39例肾功能衰竭期组、35例尿毒症期组患者的全段甲状旁腺激素(i-PTH),并和41例正常对照组进行比较。结果:i-PTH浓度病例组与正常对照组有显著性差异(P<0.01),各组间i-PTH也有显著性差异(P<0.01)。结论:慢性肾功能不全的患者,随着肾功能的恶化i,-PTH有逐渐升高的趋势。 Objective To observe intact parathyroid hormone in kidney disease with clinical application.Methods Plasma i-PTH level was measured in 46 patients with chronic renal insufficiency lose compensation stage,39 patients with chronic renal failure,35 patients with uremia.Besides,control group(n=41) was established.Results Result shown that plasma i-PTH levels were experiment group and control group were obvious difference(P0.01),among experiment group plasma i-PTH level was obvious difference(P0.01).Conclusion Results suggested along with renal function were worsen that plasma i-PTH level increasing gradually during renal insufficiency.
出处 《放射免疫学杂志》 CAS 2011年第5期490-492,共3页 Journal of Radioimmanology
关键词 全段甲状旁腺激素( i-PTH) 慢性肾功能不全 肾功能衰竭 intact parathyroid hormone chronic renal insufficiency chronic renal failure(CRF)
  • 相关文献

参考文献7

二级参考文献9

  • 1[1]Llach F,Bover J. Renal osteodystrophy[A]. In:Brenner BM ed. The kidney[M]. Philadelphia: WB Saunders, 2000. 2103-2186.
  • 2[2]Canalejo A,Almaden Y,Torregrosa V,et al. The in vitro effect of calcitriol on parathyroid cell proliferation and apoptosis[J].J Am Soc Nephrol,2000,11(10):1865-1872.
  • 3[3]Klin M,Smogorzewski M,Ni Z,et al. Abnormalities in hepatic lipase in chronic renal failure:role of excess parathyroid hormone[J]. J Clin Invest, 1996,97(10): 2167-2173.
  • 4[4]Llach F, Velasquez-Forero F. Secondary hyperparathyroidism in chronic renal failure:pathogenic and clinical aspects[J]. Am J Kinney Dis,2001,38(5 Suppl 5) :S20-S33.
  • 5[5]Moist LM, Port FK, Orzol SM, et al. Predictors of loss of residual renal function among new dialysis patients[J]. J Am Soc Nephrol,2000,11(3):556-564.
  • 6[6]De Boer IH,Gorodetskaya I, Young B, et al. The severity of secondary hyperparathyroidism in chronic renal insufficiency is GFR-dependent, race-dependent, and associated with cardiovascular disease [J ]. J Am Soc Nephrol, 2002,13 (11): 2762-2769.
  • 7Sherrard D J,Kidney Int,1993年,43卷,436页
  • 8Pei Y,Kidney Int,1992年,41卷,1374页
  • 9Li Y C,Endocrinology,1998年,139卷,4391页

共引文献29

同被引文献54

  • 1全国eGFR课题协作组.MDRD方程在我国慢性肾脏病患者中的改良和评估[J].中华肾脏病杂志,2006,22(10):589-595. 被引量:697
  • 2吴志美.糖尿病肾病尿β_2-微球蛋白、转铁蛋白的测定[J].检验医学与临床,2007,4(1):32-33. 被引量:14
  • 3Gal-Moscovici A,Sprague SM. Role of vitamin D deficiency inchronic kidney disease [J], Bone Miner Res, 2007 , 22 (2): 891-894.
  • 4National Kidney Foundation. K/DOQI clinical practice guidelinesfor chronic kidney disease . evaluation, classification, and stratifica-tion[J]. Am J Kidney Dis,2002,39(2 suppl 1) :241-246.
  • 5Theman TA, Collins MT, Dempster DW, et al. PTH replacementtherapy in a child with hypoparat hyroidism caused by a sporadiccalcium receptor mutation[J]. Bone Miner Res,2009,24(5): 964-973.
  • 6Zoccali C, Panuccio V,Tripepi G, et al. Leptin and biochemicalmarkers of bone turnover in dialysis patients[J]. Nephrol, 2004,17(2):253-260.
  • 7苗华,潘明明.慢性肾衰竭高磷血症研究及治疗进展[J].中国血液净化,2007,6(9):500-502. 被引量:24
  • 8Chude kJ,Adamczak M.Relationship betweenbody composition,sex hormones and leptinemia in hemodialyzed patients with chro-mic renal failure[J].Clinical Nephrology,2002,4(2):233.
  • 9Johansen KL.Testosterone metabolism and replacement therapy in patients with end-stage renal disease[J].Seminars in Dialysis,2004,5(2):802.
  • 10Zhang L, Wang F, Wang L, et al. Prevalence of chronic kidney dis-ease in China: a cross-sectional survey[J]. Lancet, 2012, 379 (9818) :815-822.

引证文献8

二级引证文献31

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部